The Nigeria Center for Disease Control (NCDC) is
investigating the blood clotting in some persons who received the first jab of
the AstraZeneca vaccine.
The Director General, Chikwe Ihekweazu, spoke to the press
at the Presidential Task Force (PTF) on COVID-19 briefing.
On Tuesday, the European Medicines Agency announced there’s
a causal link between AstraZeneca’s jab and rare blood clots.
Marco Cavaleri, Head of Health Threats and Vaccine Strategy, told Rome’s Il Messaggero newspaper that a definitive statement will be released this week.
Ihekweazu said the government was aware of the blood
clotting in individuals in Europe.
“Those investigations are still ongoing. Not all European
countries are adopting the vaccines for their populations,” he said.
The DG assured that Nigeria has a system to measure and
monitor any side effects.
Ihekweazu said the National Agency for Food Drugs
Administration and Control (NAFDAC) and the National Primary Health Care
Development Agency (NPHCDA) are on top of the situation.
“Actions will be taken after data and circumstances are
fully evaluated,” the NCDC chief added.
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com